| DC Field | Value | Language |
|---|
| dc.contributor.author | D FATTY LIVER DISEASE Rakhmatullaeva G. K. Sadullaeva U. A. Abdunazarova Z. A. Tashkent State Medical University | - |
| dc.date.accessioned | 2026-02-17T06:33:54Z | - |
| dc.date.available | 2026-02-17T06:33:54Z | - |
| dc.date.issued | 2026-02-16 | - |
| dc.identifier.issn | 2938-3765 | - |
| dc.identifier.uri | http://repo.tma.uz/xmlui/handle/1/3077 | - |
| dc.description.abstract | Abstract
The prevalence of metabolic syndrome (MS), non-alcoholic fatty liver disease (NAFLD), and non- alcoholic fatty pancreatic disease (NAFPD) accounts for one-quarter to one-third of the world’s population. It has been proven that the key pathogenetic mechanisms of these conditions are disorders of lipid and carbohydrate metabolism. A high comorbidity between NAFLD and NAFPD has been demonstrated: 67.9% of patients with NAFPD were found to have hepatic steatosis, and 96.8% of patients with NAFLD were diagnosed with pancreatic steatosis. | en_US |
| dc.language.iso | en | en_US |
| dc.title | ASSESSMENT OF MAIN LIPID METABOLISM INDICATORS IN PATIENTS WITH CHRONIC PANCREATITIS AND METABOLICALLY ASSOCIATED FATTY LIVER DISEASE | en_US |
| dc.type | Article | en_US |
| Appears in Collections: |
|
